Genesis Healthcare, Inc. (GEN): Price and Financial Metrics

Genesis Healthcare, Inc. (GEN): $22.40

0.30 (+1.36%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

B

Add GEN to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#16 of 65

in industry

GEN Price/Volume Stats

Current price $22.40 52-week high $24.37
Prev. close $22.10 52-week low $15.45
Day low $22.15 Volume 3,053,100
Day high $22.44 Avg. volume 4,452,172
50-day MA $22.05 Dividend yield 2.3%
200-day MA $20.34 Market Cap 14.27B

GEN Stock Price Chart Interactive Chart >

GEN POWR Grades

  • Quality is the dimension where GEN ranks best; there it ranks ahead of 87.29% of US stocks.
  • The strongest trend for GEN is in Value, which has been heading up over the past 26 weeks.
  • GEN ranks lowest in Growth; there it ranks in the 41st percentile.

GEN Stock Summary

  • GEN has a higher market value than 86.4% of US stocks; more precisely, its current market capitalization is $14,390,464,964.
  • GEN's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 85.38% of US stocks.
  • Revenue growth over the past 12 months for GEN DIGITAL INC comes in at 31.46%, a number that bests 85.18% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to GEN, based on their financial statements, market capitalization, and price volatility, are CARS, TWOU, SANW, HOLX, and GNRC.
  • GEN's SEC filings can be seen here. And to visit GEN DIGITAL INC's official web site, go to www.nortonLifeLock.com.

GEN Valuation Summary

  • In comparison to the median Technology stock, GEN's price/sales ratio is 58.33% higher, now standing at 3.8.
  • Over the past 243 months, GEN's price/sales ratio has gone down 2.4.

Below are key valuation metrics over time for GEN.

Stock Date P/S P/B P/E EV/EBIT
GEN 2023-12-08 3.8 5.9 10.0 20.9
GEN 2023-12-07 3.8 5.9 10.1 20.9
GEN 2023-12-06 3.8 5.9 10.0 20.9
GEN 2023-12-05 3.8 5.9 10.1 20.9
GEN 2023-12-04 3.8 6.0 10.2 21.1
GEN 2023-12-01 3.8 5.9 10.1 21.0

GEN Growth Metrics

    The 5 year price growth rate now stands at -27.84%.
  • Its 5 year net income to common stockholders growth rate is now at 3766.98%.
  • The 3 year net cashflow from operations growth rate now stands at -34.85%.
GEN's revenue has moved up $617,000,000 over the prior 34 months.

The table below shows GEN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 3,107 759 554
2022-09-30 2,873 783 591
2022-06-30 2,817 931 855
2022-03-31 2,796 974 836
2021-12-31 2,752 1,004 910
2021-09-30 2,689 967 886

GEN Price Target

For more insight on analysts targets of GEN, see our GEN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $0.54 Average Broker Recommendation 2.25 (Moderate Sell)

Genesis Healthcare, Inc. (GEN) Company Bio


Genesis Healthcare provides post-acute care services through a network of skilled nursing centers and assisted/senior living communities in the United States. It operates through three segments: Long-Term Care Services, Therapy Services, and Hospice and Home Health Services. The company was founded in 2003 and is based in Kennett Square, Pennsylvania.


GEN Latest News Stream


Event/Time News Detail
Loading, please wait...

GEN Latest Social Stream


Loading social stream, please wait...

View Full GEN Social Stream

Latest GEN News From Around the Web

Below are the latest news stories about GEN DIGITAL INC that investors may wish to consider to help them evaluate GEN as an investment opportunity.

7 Compelling Tech Stocks to Snag From the Discount Bin

You don’t need to be a Wall Street expert to realize that innovators dominated the equities space in 2023.

Josh Enomoto on InvestorPlace | December 27, 2023

Why These 3 Growth Stocks Should Be on Your Radar in 2024

Are you looking to build your portfolio in 2024?

Marc Guberti on InvestorPlace | December 23, 2023

Best Growth Stocks 2024: 7 to Add to Your Must-Buy List

Many investors made it a point to avoid growth stocks after a disastrous 2022, but long-term investors were rewarded this year.

Marc Guberti on InvestorPlace | December 22, 2023

Jacobs Solutions (J) Up 1.8% Since Last Earnings Report: Can It Continue?

Jacobs Solutions (J) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 21, 2023

How To Make Sustainability Part of Your Holiday Season

NORTHAMPTON, MA / ACCESSWIRE / December 20, 2023 / Gen By Amanda Davis The holidays are here again. For many of us, this time of year means gifts, gatherings, eating and good memories as we celebrate with friends and family. The trouble is, all that ...

Yahoo | December 20, 2023

Read More 'GEN' Stories Here

GEN Price Returns

1-mo 4.67%
3-mo -1.26%
6-mo 28.23%
1-year 37.01%
3-year 13.47%
5-year 8.63%
YTD -1.26%
2023 9.29%
2022 -15.81%
2021 27.59%
2020 -16.60%
2019 37.17%

GEN Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full GEN Dividend History

Continue Researching GEN

Here are a few links from around the web to help you further your research on Genesis Healthcare Inc's stock as an investment opportunity:

Genesis Healthcare Inc (GEN) Stock Price | Nasdaq
Genesis Healthcare Inc (GEN) Stock Quote, History and News - Yahoo Finance
Genesis Healthcare Inc (GEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!